Company intelligence / Profile preview
Atavistik Bio
Cambridge, Massachusetts, United Statesatavistikbio.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Atavistik Bio has established a pipeline of precision allosteric small molecule therapeutics targeting serious unmet needs in oncology. Its lead candidate, ATV-1601—a selective allosteric inhibitor for solid tumors with AKT1 E17K mutations—is expected to enter clinical trials in early 2025. The company’s AMPS™ platform enables rapid identification of novel functional allosteric sites across challenging target classes. No clinical results are available yet as the programs are preclinical/IND-enabling.
- Therapeutic areas
- Oncology
- Modalities
- Small molecules (precision allosteric small molecule therapeutics)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Pfizer – research collaboration leveraging AMPS™ platform for two undisclosed targets
Beyond the preview
Go deeper on Atavistik Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atavistik Bio.